STOCK TITAN

[Form 4] TNF Pharmaceuticals, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Form 4 shows Billy Joe White, a director of Q/C Technologies, Inc. (ticker QCLS), received a grant of 2,161 Restricted Stock Units (RSUs) that vested immediately on 10/03/2025. The RSUs were recorded at a $0 per-share acquisition price because they were granted as restricted units rather than purchased shares. After the transaction, the reporting person beneficially owns 2,185 shares directly. The Form 4 is signed and dated 10/06/2025.

This filing records an equity compensation event for an insider rather than an open-market purchase or sale; the immediate vesting increases the director’s direct stake by the stated share count and is reportable under Section 16(a).

Modulo 4 mostra Billy Joe White, un regista di Q/C Technologies, Inc. (ticker QCLS), ha ricevuto una assegnazione di 2.161 Restricted Stock Units (RSU) che si sono mature immediatamente il 10/03/2025. Le RSU sono state registrate a un prezzo di acquisizione di $0 per azione perché sono state concesse come unità restrittive piuttosto che azioni acquistate. Dopo la transazione, la persona che riporta detiene beneficiariamente 2.185 azioni direttamente. Il Form 4 è firmato e datato 10/06/2025.

Questo deposito registra un evento di compensazione azionaria per un insider piuttosto che un acquisto o vendita sul mercato aperto; la vesting immediata aumenta la partecipazione diretta del direttore per il numero di azioni indicato ed è riportabile ai sensi della Sezione 16(a).

Formulario 4 muestra a Billy Joe White, un director de Q/C Technologies, Inc. (símbolo QCLS), recibió una asignación de 2,161 Unidades de Acciones Restringidas (RSU) que se consolidaron de inmediato el 10/03/2025. Las RSU se registraron a un precio de adquisición de $0 por acción porque se otorgaron como unidades restringidas en lugar de acciones adquiridas. Después de la transacción, la persona que presenta el informe posee de forma beneficiosa 2,185 acciones directamente. El Formulario 4 está firmado y fechado el 10/06/2025.

Esta presentación registra un evento de compensación de capital para un insider en lugar de una compra o venta en el mercado; la consolidación inmediata aumenta la participación directa del director en la cantidad de acciones indicada y debe reportarse conforme a la Sección 16(a).

양식 4Billy Joe White를 보여주며, Q/C Technologies, Inc.의 이사이고 종목 코드 QCLS인 사람은 2,161개의 제한 주식 단위(RSU)를 받았고 즉시 vest 되었습니다 2025/10/03. RSU는 실질적 주식이 아닌 제한 단위로 부여되어 $0의 주당 취득가로 기록되었습니다. 거래 후 보고자은 직접적으로 2,185주를 보유하게 됩니다. 양식 4는 2025/10/06에 서명되었고 날짜가 적혀 있습니다.

이 제출은 공개 시장의 매수나 매도가 아닌 내부자에 의한 주식 보상 이벤트를 기록하며, 즉시 vesting은 이사의 직접 지분을 명시된 주식 수만큼 증가시키고 제16(a)조에 따라 보고됩니다.

Formulaire 4 montre Billy Joe White, un directeur de Q/C Technologies, Inc. (ticker QCLS), a reçu une attribution de 2 161 unités d’actions restreintes (RSU) qui ont été acquises immédiatement le 03/10/2025. Les RSU ont été enregistrées à un prix d’acquisition de $0 par action, car elles ont été accordées en tant qu’unités restreintes plutôt que des actions achetées. Après la transaction, la personne déclarante détient directement 2 185 actions bénéficairement. Le Formulaire 4 est signé et daté du 06/10/2025.

Cette notification enregistre un événement de compensation d’action pour un initié plutôt qu’un achat ou une vente sur le marché ouvert; l’acquisition immédiate augmente la participation directe du directeur du nombre d’actions indiqué et doit être reportée selon la Section 16(a).

Formular 4 zeigt Billy Joe White, einen Direktor von Q/C Technologies, Inc. (Ticker QCLS), der eine Zuweisung von 2.161 Restricted Stock Units (RSUs) erhalten hat, die unverzüglich vesteten am 03.10.2025. Die RSUs wurden mit einem 0 $ pro Aktie Anschaffungspreis aufgezeichnet, da sie als eingeschränkte Einheiten statt als gekaufte Aktien gewährt wurden. Nach der Transaktion besitzt die berichtende Person direkt 2.185 Aktien. Das Formular 4 ist unterschrieben und datiert am 06.10.2025.

Dieses Filing dokumentiert einen Eigenkapital-Beteiligungsvorfall für einen Insider statt eines Öffentlichen Markt-Kaufs oder -Verkaufs; die sofortige Vesting erhöht den direkten Anteil des Direktors um die angegebene Aktienanzahl und ist gemäß Abschnitt 16(a) meldepflichtig.

النموذج 4 يعرض بیلي جو وايت، مدير في Q/C Technologies, Inc. (الرمز QCLS), تلقى منحة قدرها 2,161 وحدة أسهم مقيدة (RSUs) التي ارتفعت فورا في 2025/10/03. تم تسجيل RSUs بسعر اكتساب قدره $0 للسهم الواحد لأنها منحت كوحدات مقيدة بدلاً من أسهم مباعة. بعد الصفقة، يمتلك الشخص المبلغ عن نفسه بصفة مستفيدة 2,185 سهمًا بشكل مباشر. النموذج 4 موقّع ومؤرخ في 2025/10/06.

هذا filing يسجل حدث تعويضي للأسهم لمواطن داخلي بدلاً من شراء أو بيع في السوق المفتوح؛ ال vesting الفوري يزيد حصة المدير المباشرة بعدد الأسهم المذكور ويجب الإبلاغ عنه وفق القسم 16(a).

Form 4 显示 Billy Joe White,Q/C Technologies, Inc. 的一名 董事,股票代码 QCLS,获得了 2,161 份受限股票单位 (RSUs),这些 RSU 已立即归属,日期为 2025/10/03。由于它们作为受限单位而非购买的股票授予,因此 RSU 的每股取得价格记为 $0。交易结束后,报告人直接受益地拥有 2,185 股。Form 4 签章并日期为 2025/10/06

本次备案记录的是内部人士的股权补偿事件,而非公开市场上的购买或出售;立即归属会增加董事的直接持股数量,并且应按照第 16(a) 条进行披露。

Positive
  • Director alignment increased via an immediate grant of 2,161 RSUs
  • Direct beneficial ownership rose to 2,185 shares, strengthening insider stake
Negative
  • None.

Insights

Director received immediately vested RSUs, increasing direct ownership by 2,161 shares.

The grant of 2,161 RSUs that vested on 10/03/2025 is a standard executive/director equity award converting to direct share ownership without an outlay by the insider, shown at $0 acquisition price because no cash was paid. This increases the reporting person’s direct beneficial ownership to 2,185 shares.

Such awards affect dilution and align long-term interests but do not reflect open-market demand; monitor outstanding share count and subsequent disposals within the next 6–12 months for trading or retention signals.

Immediate vesting indicates a one-time grant or accelerated award rather than a scheduled vesting tranche.

Immediate vesting of RSUs typically follows board action such as a sign-on, special grant, or acceleration of prior awards; here the disclosure simply records grant and vesting on 10/03/2025. The filing does not disclose the grant rationale, total award program, or whether taxes were withheld in kind.

Investors can look for related disclosures in proxy statements or later filings to see if this was part of a broader compensation plan; review future Form 4s for any sale or withholding transactions within the next fiscal quarter.

Modulo 4 mostra Billy Joe White, un regista di Q/C Technologies, Inc. (ticker QCLS), ha ricevuto una assegnazione di 2.161 Restricted Stock Units (RSU) che si sono mature immediatamente il 10/03/2025. Le RSU sono state registrate a un prezzo di acquisizione di $0 per azione perché sono state concesse come unità restrittive piuttosto che azioni acquistate. Dopo la transazione, la persona che riporta detiene beneficiariamente 2.185 azioni direttamente. Il Form 4 è firmato e datato 10/06/2025.

Questo deposito registra un evento di compensazione azionaria per un insider piuttosto che un acquisto o vendita sul mercato aperto; la vesting immediata aumenta la partecipazione diretta del direttore per il numero di azioni indicato ed è riportabile ai sensi della Sezione 16(a).

Formulario 4 muestra a Billy Joe White, un director de Q/C Technologies, Inc. (símbolo QCLS), recibió una asignación de 2,161 Unidades de Acciones Restringidas (RSU) que se consolidaron de inmediato el 10/03/2025. Las RSU se registraron a un precio de adquisición de $0 por acción porque se otorgaron como unidades restringidas en lugar de acciones adquiridas. Después de la transacción, la persona que presenta el informe posee de forma beneficiosa 2,185 acciones directamente. El Formulario 4 está firmado y fechado el 10/06/2025.

Esta presentación registra un evento de compensación de capital para un insider en lugar de una compra o venta en el mercado; la consolidación inmediata aumenta la participación directa del director en la cantidad de acciones indicada y debe reportarse conforme a la Sección 16(a).

양식 4Billy Joe White를 보여주며, Q/C Technologies, Inc.의 이사이고 종목 코드 QCLS인 사람은 2,161개의 제한 주식 단위(RSU)를 받았고 즉시 vest 되었습니다 2025/10/03. RSU는 실질적 주식이 아닌 제한 단위로 부여되어 $0의 주당 취득가로 기록되었습니다. 거래 후 보고자은 직접적으로 2,185주를 보유하게 됩니다. 양식 4는 2025/10/06에 서명되었고 날짜가 적혀 있습니다.

이 제출은 공개 시장의 매수나 매도가 아닌 내부자에 의한 주식 보상 이벤트를 기록하며, 즉시 vesting은 이사의 직접 지분을 명시된 주식 수만큼 증가시키고 제16(a)조에 따라 보고됩니다.

Formulaire 4 montre Billy Joe White, un directeur de Q/C Technologies, Inc. (ticker QCLS), a reçu une attribution de 2 161 unités d’actions restreintes (RSU) qui ont été acquises immédiatement le 03/10/2025. Les RSU ont été enregistrées à un prix d’acquisition de $0 par action, car elles ont été accordées en tant qu’unités restreintes plutôt que des actions achetées. Après la transaction, la personne déclarante détient directement 2 185 actions bénéficairement. Le Formulaire 4 est signé et daté du 06/10/2025.

Cette notification enregistre un événement de compensation d’action pour un initié plutôt qu’un achat ou une vente sur le marché ouvert; l’acquisition immédiate augmente la participation directe du directeur du nombre d’actions indiqué et doit être reportée selon la Section 16(a).

Formular 4 zeigt Billy Joe White, einen Direktor von Q/C Technologies, Inc. (Ticker QCLS), der eine Zuweisung von 2.161 Restricted Stock Units (RSUs) erhalten hat, die unverzüglich vesteten am 03.10.2025. Die RSUs wurden mit einem 0 $ pro Aktie Anschaffungspreis aufgezeichnet, da sie als eingeschränkte Einheiten statt als gekaufte Aktien gewährt wurden. Nach der Transaktion besitzt die berichtende Person direkt 2.185 Aktien. Das Formular 4 ist unterschrieben und datiert am 06.10.2025.

Dieses Filing dokumentiert einen Eigenkapital-Beteiligungsvorfall für einen Insider statt eines Öffentlichen Markt-Kaufs oder -Verkaufs; die sofortige Vesting erhöht den direkten Anteil des Direktors um die angegebene Aktienanzahl und ist gemäß Abschnitt 16(a) meldepflichtig.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
White Billy Joe

(Last) (First) (Middle)
1185 AVENUE OF THE AMERICAS,
SUITE 249

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Q/C TECHNOLOGIES, INC. [ QCLS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 10/03/2025 A 2,161 A $0(1) 2,185 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of Restricted Stock Units ("RSUs"). The RSUs vested immediately upon grant on October 3, 2025.
/s/ Billy Joe White 10/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did TNFA director Billy Joe White report on Form 4?

He reported a grant of 2,161 RSUs that vested immediately on 10/03/2025, increasing his direct ownership to 2,185 shares.

Was there a purchase price for the shares reported on the Form 4?

No; the RSUs are shown with an acquisition price of $0 because they were granted rather than bought.

Does this Form 4 show a sale or open-market purchase by the insider?

No; the filing documents a grant and immediate vesting of RSUs, not a market purchase or disposition.

When did the RSUs vest according to the filing?

The RSUs vested immediately upon grant on 10/03/2025, per the explanation in the filing.

How does the Form 4 affect reported beneficial ownership for TNFA insiders?

It increases the reporting person’s direct beneficial ownership to 2,185 shares following the vested RSU grant.
TNF Pharmaceuticals

NASDAQ:TNFA

TNFA Rankings

TNFA Latest News

TNFA Latest SEC Filings

TNFA Stock Data

9.60M
1.85M
0.01%
0.3%
3.21%
Biotechnology
In Vitro & in Vivo Diagnostic Substances
Link
United States
NEW YORK